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Cervical erosion is a common condition seen in most 
women of all the age groups. About 85% women 
suffer from the cervical erosion i.e. benign condition 
of female genital tract during their lifetime.
[1]
 It is 
asymptomatic in initial stage but later on it progresses 
to show many symptoms like white discharge, itching 
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vulva, dyspareunia etc. It adversely affects the 
physiological and psychological health of women and 
even interferes in their professional life. It may even 
lead to infertility.
[2]
 It can show malignant changes in 
chronic stage.
[3]
 Cervical cancer is one of the most 
common cancers in women worldwide with about 
5,28,000 new cases in 2012 resulting in 2,66,000 
deaths from cervical cancer worldwide in 2012, 
accounting for 7.5% of all female cancer deaths. 
Almost nine in ten (87%) cervical cancer deaths occur 
in less developed regions.
[4]
 Cervical cancer is ranked 
as the most frequent cancer in women in India. The 
current estimates indicate approximately 132,000 
new cases diagnosed and 74,000 deaths annually in 
India; accounting to nearly 1/3
rd
 of the global cervical 
cancer deaths.
[5]
 High-quality screening with cytology 
(Pap smear) has markedly reduced mortality from 
squamous cell cervical cancer, which comprises 80% 
to 90% of cervical cancers. Cytology (Pap test) 
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screening has been very successful in lowering cancer 
incidence and mortality in countries where good-
quality screening is available.
[6] 
While going through the Ayurvedic literature it 
becomes evident that all the gynaecological disorders 
are included in Yonivyapad and Streeroga. Direct 
reference regarding the cervical pathology cannot be 
traced in Ayurvedic Classics. However, considering the 
pathology and main symptoms of that is discharge 
and erosion, it can be correlated with 
Garbhashayagrivagata Vrana. The present study is 
aimed to find out a method of treatment, which was 
impart a permanent, easy, effective cure and was with 
normal side effect, which was accepted by the 
patient. Some of the drugs like Darvi (Barberies 
aristata DC.), Lodhra (Symplocos recemosa Roxb.), 
Haridra (Curcuma longa Linn), Sphatika (alum) and 
Gairika (red ochre) has been mentioned in Upadansha 
Chikitsa
[7] 
were selected for Yoni Varti (vaginal 
suppository). Drugs like Sphatika, Darvi, Haridra and 
Lodhra having Vranashodhana, Ropana and 
Prasadhana properties were selected for Yoni Varti 
preparation.
 
OBJECTIVES OF THE STUDY 
To evaluate the efficacy of Darvyadi Yoni Varti on 
cervical erosion. 
MATERIALS AND METHODS 
It was an open label single arm clinical study 
conducted at Streeroga and Prasutitantra Out Patient 
Department (OPD), I.P.G.T. and R.A. Jamnagar. 
Patients 
Patients (N=43) attending the out patient department 
of Prasutitantra and Streeroga, fulfilling the criteria 
for the selection were selected for the study. A 
detailed history was taken according to the proforma 
specially prepared for this purpose. 
Drugs 
The raw drugs of Yoni Varti (vaginal suppository) were 
collected from the Pharmacy of Gujarat Ayurved 
University and authenticated in the Pharmacognosy 
Laboratory, I.P.G.T. and R.A. Jamnagar. Vaginal 
suppository was prepared in the department of 
Rasashashtra and Bhaishajya Kalpana. Table 1 shows 
the ingredients of Yoni Varti. 
Table 1: Ingredients of Darvyadi Yoni Varti 
SN Ingredients  For 1 tab. of 3 gm. 
1. Kwatha (Darvi, Lodhra, 
Haridra) 
2.5ml 
2. Madhu 0.16ml 
3. Shu. Sphatika 0.06gm 
4. Shu. Gairika 0.05gm 
5. Gelatin powder 1.3gm 
6. Propyl Para Ben Sodium Salt 0.01gm 
Ethical clearance 
The study was cleared by the Institutional Ethics 
Committee (PGT/7-A/Ethics/2012-2013/3532) and 
registered in Clinical Trial Registry of India (CTRI) No. 
CTRI//2014/01/00623.Prior to initiation of the study, 
informed written consent was taken from each 
patient. Patients were asked to withdraw their name 
from the study at any time without giving any reason 
if they wish. 
Inclusion criteria 
Married patients of aged between 20 to 60 years with 
clinical signs and symptoms of cervical cell pathology 
including white discharge, contact bleeding, backache, 
erosion, hypertrophy, Acute and Chronic Cervicitis, 
Cervical intraepithelial neoplasia (CIN) I and II (As per 
CIN classification) in Pap smear test were enrolled in 
the study. 
Exclusion criteria 
Patients with Tuberculosis of uterus, Procedentia, CIN 
Grade III (As per Bethesda classification), TB, DM, 
S.T.D., H.I.V., Pregnant and lactating women, aged <20 
and > 60 years were excluded from study. 
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Posology 
The treatment protocol comprised of Darvyadi Yoni 
Varti of 3 gm once at bed time for 21 days. The 
assessment was done with subjective criteria and pap-
smear after 45 days. 
Criteria for assessment 
Assessment was done on the basis of improvement in 
signs and symptoms of the disease, Changes in Pap 
smear report, improvement in other investigatory 
parameters. A special scoring pattern was adopted for 
the signs and symptoms. 
OBSERVATION AND RESULTS 
In this clinical study, total 43 patients were registered, 
out of which 41 patients completed the treatment, 
whereas two patients discontinued. In the present 
study, maximum number of patients, i.e. 41.86% 
belonged to age group of 20-30 years, 46.51% were 
from lower middle class, 53.49% were multipara, 
62.79% were from rural area, 100% had Yoni Srava 
(vaginal discharge) and 41.86% had been suffering for 
1-2 year. 
Pap-smear report shows that 24 patients had chronic 
cervicitis while 7 patients had acute cervicitis, 7 had 
acute on chronic cervicitis, 3 had benign hypertrophy 
and 1 patient had CIN-1 respectively. 
Highly significant relief was observed in the Yonitah 
Srava (Vaginal discharge) (68.75%, p<0.001), Yoni 
Kandu (Itching vulva) (70.83%, p<0.001), Kati Shoola 
(Backache) (56.94%, p<0.001), Udara Shoola (Lower 
abdominal pain) (70%, p<0.001), Mutra Daha (Burning 
micturition) (74.07%, p<0.001), Daurbalya (Weakness) 
(63.83%, p<0.001). Significant relief was observed in 
Yoni Daha (Burning sensation in vagina) (76.92, 
p<0.05). (Table-2) 
Table 2: Effect of therapy on clinical features 
N Chief 
complaints 




41 Yonitah Srava 2.341 0.731 68.75 861 <0.001 
30 Yoni Kandu 1.6 0.466 70.83 465 <0.001 
10 Yoni Daha 1.3 0.3 76.92 55 <0.05 
35 Kati Shoola 2.057 0.885 56.94 630 <0.001 
13 Udara Shoola 1.538 0.461 70 91 <0.001 
15 Mutradaha 1.8 0.466 74.07 120 <0.001 
28 Daurbalya 1.678 0.607 63.83 406 <0.001 
N= number of pairs in Wilcoxon’s signed-rank test 










% Area of 
Erosion 
1.195 0.195 83.67 820 <0.001 
41 Appearance 1.707 0.536 68.57 861 <0.001 
N= number of pairs in Wilcoxon’s signed-rank test 
Table 3 shows the statistically highly significant relief 
in the % area of cervical erosion and appearance in 
per speculum finding. 
Effect of therapy on cytology reports shows after 
treatment normal cytology was observed in 6 patients 
of chronic cervicitis, 3 patients of acute cervicitis, 1 
patient of acute on chronic cervicitis and 2 patients of 
benign hypertrophy. Decrease in infection with repair 
changes was observed in 10 patients of chronic 
cervicitis, 3 patients of acute cervicitis, 5 patients of 
acute on chronic cervicitis. No change was observed in 
5 patients of chronic cervicitis, 1 patient of acute 
cervicitis. Infection was increased in 3 patients of 
chronic cervicitis, 1 patients of benign hypertrophy 
and 1 patient of normal cytology report. (Table 4) 
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Table 4: Effect of therapy on cytology  
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The total effect of therapy shows that 2
patients had got complete remission, 35.
got marked improvement, 56.10% p
moderate improvement and 4.87% patie
mild improvement. (Figure 1) 
 
Figure 1: Total effect of therapy  
DISCUSSION 
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 (re-growth of the tissue) 
leading to minimal inflammation.  
The modern technology has proved that drugs of 
Darvyadi Yoni Varti has anti-inflammatory, 
antimicrobial, anti-bacterial, hypoglycaemic, anti-




 by which it kills the 
causative microorganism, reduces inflammation and 
also supports the vaginal defense mechanism. 
CONCLUSION 
The present study is aimed to find out a method of 
treatment, which was impart a permanent, easy, 
effective cure and was with normal side effect, which 
was accepted by the patient. The study is overall 
concluded that the Darvyadi Yoni Varti is highly 
effective in reducing subjective and objective 
variables of Garbhashaya Mukhagata Vrana (cervical 
erosion) and will also help in deriving new conclusion 
and axioms in the management of Garbhashaya 
Mukhagata Vrana (cervical erosion). No Adverse Drug 
Reaction (ADR) and side effects were reported in the 
present study. 
REFERENCES 
1. Neelam, Neeraj K., management of cervical erosion, 
AYU Journal, 2009: 30(2);p.171-174. 
2. Vaclav insler and Bruno lunenfeld, Infertility; Male and 
Female Churchill Living Stone, 2nd Edition Dignosis and 
Classification of sperm – mucus interaction, 1993;p.345 
3. Shaw, textbook of Gynaecology, Carcinoma of the 
cervix-25, edided by V. Padubidri and Shirish N. 
Daftary, B.I. Churchill Livingstone PVT Ltd-New Delhi 
publication, 11th edition 1994;p.428. 
4. Ferlay J, Isabelle S, Rajesh D, Esaer S, Colin M, Rebelo 
M. Cancer incidence and mortality worldwide: Sources, 
methods and major patterns in GLOBOCAN 2012. 
International journal of cancer 2015;136(5):E359-86. 
5. Kaarthigeyan K. Cervical cancer in india and HPV 
vaccination. Indian journal of medical and paediatric 
oncology: Official journal of Indian society of medical 
and paediatric oncology.2012;33(1):p.7-12.  
6. Saslow D, Solomon D, Herschel W, Maureen K, Shalini 
L, Joanaa C etc.  American cancer society, American 
society for colposcopy and cervical pathology, and 
American society for clinical pathology screening 
guidelines for the prevention and early detection of 
cervical cancer, A Cancer Journal for Clinicians 
2012:62(3):p.147–172. 
7. Ambikadutta S, editor, Sushruta Samhita of Sushruta, 
Chikitsa Sthana; Vridhhupadamshashlipada Chikitsa: 
Chapter 19, Verse 40. Varanasi: Chaukhambha 
Sanskrita Sansthan; 2011;p.113. 
8. Khan MJ, Partridge EE, Wang SS, Schiffman M. 
Socioeconomic status and the risk of cervical 
intraepithelial neoplasia grade 3 among oncogenic 
human papillomavirus DNA-positive women with 
equivocal or mildly abnormal  cytology. Cancer 
2005;104:p.61-70. 
9. Manjit B, Rishu G, Anil S, Manjit Kaur M. Detection of 
abnormal cervical cytology in Papanicolaou smears, J 
Cytology 2012;29(1):p.45 - 47. 
10. Agnivesh, Charaka Samhita, Sutra Sthana, 26/42, 
Chakrapani Rachita Ayurvedadipika Commentary,  
Vaidya YT Acharya editor, Varanasi: Chaukhambha 
Prakashana, 2007;p.348 
11. Agnivesh, Charaka Samhita, Sutra Sthana, 26/42, 
Chakrapani Rachita Ayurvedadipika Commentary, 
Vaidya YT Acharya editor, Varanasi: Chaukhambha 
Prakashana, 2007;p.345 
12. Anonymous. Data Base on Medicinal Plants used in 
Ayurveda and Siddha, Vol. 1. Delhi: Central Council for 
Research in Ayurveda and Siddha, Department of 
AYUSH; 2002;p.152 
13. Bhavamishra, Bhavaprakasha Nighantu, Madhu Varga: 
21/2 Chunekar K, editor, (revised and enlarged ed.). 
Varanasi: Chaukhamba Bharati Academy, 2010;p.772 
 
******************************* 
How to cite this article: Amit V. Rupapara,  Shilpa B. 
Donga,  Laxmipriya Dei. Effect of Darvyadi Yoni Varti in 
the management of Garbhasaya Mukhagata Vrana 
(Cervical erosion) - An Open label clinical trial. J 
Ayurveda Integr Med Sci 2017;3:1-5. 
http://dx.doi.org/10.21760/jaims.v2i3.8201 
 
Source of Support: Nil, Conflict of Interest: None 
declared. 
